US Food and Drug Administration revised EUA for sotrovimab due to Omicron BA.2 subvariant
On Mar. 25, 2022, GlaxoSmithKline and Vir Biotechnology announced that the US Food and Drug Administration had amended…
On Mar. 25, 2022, GlaxoSmithKline and Vir Biotechnology announced that the US Food and Drug Administration had amended…
On Mar. 25, 2022, Icosavax announced the first subjects had been dosed with IVX-411, a virus-like particle (VLP)…
On Mar. 25, 2022, the WHO and the Government of India signed an agreement to establish the WHO…
On Mar. 23, 2022, Quest Diagnostics announced that it had been granted a contract by the Centers for…
On Mar. 22, 2022, Windtree Therapeutics announced results from its Phase 2 study of lucinactant (KL4 surfactant) for…
On Mar. 21, 2022, in support of the Cancer Moonshot? goal of fostering data sharing in cancer research,…
On Mar. 17, 2022, Eiger BioPharmaceuticals announced that Peginterferon Lambda (Lambda) significantly reduced the risk of COVID-19-related hospitalizations…
On Mar. 16, 2022, Roche announced available testing solutions that can identify the SARS-CoV-2 B.1.1.529 variant and differentiate…
On Mar. 11, 2022, the BNT162b2 (Pfizer-BioNTech) mRNA COVID-19 vaccine was recommended by CDCメs Advisory Committee on Immunization…
On Mar. 10, 2022, Howard Hughes Medical Institute announced that after more than two decades of effort researchers…
On Mar. 10, 2022, Oragenics announced that it had entered into an agreement with KBI Biopharma for the…
On Mar. 9, 2022, Harvard Medical School announced that an international research team had completed an atlas of…
On Mar. 9, 2022, researchers from the National Institute of Allergy and Infectious Diseases (NIAID) announced a clinical…
On Mar. 4, 2022, Oxitec announced the publication by the U.S. Environmental Protection Agency of its approval to…
On Mar. 7, 2022, Innovation Pharma announced the Company was conducting full data analysis of the Phase 2…
On Mar. 7, 2022, the U.S. Food and Drug Administration announced it had made a low-risk determination for…
On Mar. 7, 2022, researchers from the University of Oxford have used data from UK Biobank participants to…
On Mar. 4, 2022, the CDC reported that COVID-19 vaccination coverage with the first dose of the primary…
On Mar. 4, 2022, the WHO announced it had published an updated position paper on the RTS,S/AS01 (RTS,S)…
On Mar. 3, 2022, a study carried out in southwestern Ontario identified a highly mutated variant of SARS-CoV-2…
On Mar. 3, 2022, the WHO and the Medicines Patent Pool (MPP) jointly welcomed the announcement that the…
On Mar. 2, 2022, Roche announced an initial donation of essential medicines to Ukraine. Roche is working diligently…
On Mar. 1, 2022, the CDC reported that Two doses of Pfizer-BioNTech vaccine protect against COVID-19ヨassociated emergency department…
On Feb. 25, 2022, researchers announced that wildlife reservoirs of SARS-CoV-2 can lead to viral adaptation and spillback…
On Feb. 24, 2022, researchers from the University of Oxford have used data from UK Biobank participants to…
On Feb. 23, 2022, Sanofi and GSK announced that they planned to submit data from both their booster…
On Feb. 23, 2022, Agilent Technologies announced that researchers at the Indian Institute of Technology Bombay in India…
On Jan. 24, 2022, researchers from the University of Oxfordメs Big Data Institute announced a major step towards…
On Feb. 18, 2022, the WHO announced the first six countries that will receive the technology needed to…
On Feb. 16, 2022, the McKelvey School of Engineering at Washington University in St. Louis, announced that it…